Local application of angiotensin ii to the rat carotid artery induces adventitial thickening

Journal of Vascular Research

Volumn 34, Issue 6, 1997, Pages 436-446

  Scheidegger, Kathrin J ^a   Wood, Jeanette M ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adventitial thickening; Angiogenesis; Angiotensin II; Angiotensin receptor antagonists; Collagen; PD 123319; Valsartan

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; COLLAGEN; NORADRENALIN; VALSARTAN;

ADVENTITIA; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031455142     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159254     Document Type: Article

References (43)

1. Mizuno K, Nakamura M, Higashimori K, lnagami T: Local generalion and release of angiotensin II in peripheral vascular tissue. Hypertension 1988:11:223-229.
2. Bunkenburg B, van Amelsvoort T, Rogg H, Wood JM: Receptor mediated effects of angiotensin II on growth of vascular smooth muscle cells front spontaneously hypertensive rats. Hypertension 1992:20:746-754.
3. Scott-Burdcn T, Resink TJ, Hahn AW, Biihler FR: Induction of thrombospondin expression in vascular smooth muscle cells by angiotensin 11. J Cardiovasc Pharmacol 1990; 16(suppl 7): S17-S20.
4. Owens GK: Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 1987;9:178-187.
5. Owens GK, Schwartz SM: Vascular smooth muscle cell hypertrophy and hypcrploidy in the Goldblatt hypertensive rat. Circ Res 1983;53: 491-501.
6. Prescott MG, Webb RL, Reidy MA: Angiotensin-converting enzyme inhibitor versus angiotensin II. ATI receptor antagonist: Effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol 1991;139:1291-1296.
7. Powell JS, Clozel JP, Müller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR: Inhibitors of angiotensin-converting enzyme prevent myoir.timal proliferation after vascular injury. Science 1989;245:186-188.
8. Kauffman RF, Bean JS, Zimmermann KM, Brown RF, Steinberg MI: Losartan. a nonpep-tidc angiotensin II (ANG II) receptor antagonist. inhibits neointima formation following balloon injury to rat carotid arteries. Life Sci 1991:49:223-228.
9. Daemen MJ, Lombardi DM, Bosnian FT, Schwartz SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450-456.
10. Fernandez LA, Caride VJ, Twickler J, Galardy RE: Renin-angiotensin and development of collateral circulation after renal ischemia. Am J Physiol 1982;243:H869-H875.
11. Fernandez LA, Twickler J, Mead A: Angiogen-esis produced by angiotensin II. J Lab Clin Med 1985:105:141-145.
12. LeNoble FAC, Hekking JWM, van Straatcn HWM, Slaaf DW, Struiker Boudier HAJ: Angiotensin II stimulates angiogenesis in the chorion-allantoic membrane of the chick embryo. Eur J Pharmacol 1991,195:305-306.
13. Janiak P, Pillon A, Prost J-F, Vilaine J-P: Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 1992:20:737-745.
14. Schnell CR, Wood JM: Measurement of blood pressure and heart rate by telemetry in conscious, unrestrained marmosets. Am Physiol Soc 1993; H1509-H1516.
15. de Gasparo M, Bottari S, Levens NR: Characteristics of angiotensin II receptors and their role in cell and organ physiology: in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology. Diagnosis, and Management, ed 2. New York, Raven Press, 1995, pp 1695-1720.
16. Kato H, Hou J, Chobanian AV, Brecher P: Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta. Hypertension 1996;28:153-158.
17. Ganten D, Schclling P, Flügel RM, Ganten U: Effect of angiotensin and angiotensin antagonists on iso-renin and cell growth in 3T3 mouse cells. IRCSJ Med Sci 1975;3:327-332.
18. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruto T: Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 1991:9:17-22.
19. Keeley FW, Alatawi A: Response of aortic elas-tin synthesis and accumulation to developing hypertension and the inhibitory effect of colchicine on this response. Lab Invest 1991:64: 499-507.
20. 125I] labelled angiotensin I in isolated perfused porcine coronary and carotid arteries. Cardiovasc Res 1995:29:789-795.
21. Darby I, Skalli O, Gabbiani G: α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63:21-29.
22. Weber KT, Brilla CG: Myocardial fibrosis and renin-angiotensin-aldosteronc system. J Cardiovasc Pharmacol 1992;20(suppl I):S48-S54.
23. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewsky A: Adventitial remodeling after coronary injury. Circulation 1996:93:340-348.
24. den Heijer P, Foley DP, Escancd J, Hillege HL, van Dijk RB, Serruys PW, Lie KI: Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus. J Am Coll Cardiol 1994;24:646-654.
25. Bevan RD: Effect of sympathetic denervation on smooth muscle proliferation in the growing rabbit ear artery. Circ Res 1975:37:14-19.
26. Aalto M, Kuloncn E: Effects of serotonin, indo-melhacin and other anthirheumatic drugs in the synthesis of collagen and other proteins in granulation tissue slices. Biochem Pharmacol 1972;21:2835-2840.
27. Gibbons GH, Pratt RE, Dzau VJ: Vascular smooth muscle cell hypertrophy vs. hyperplasia: Autocrine transforming growth lactor-pi expression determines growth factor response to angiotensin II. J Clin Invest 1992:90:456-461.
28. Roberts AB, Spom MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Falanga V, Kehrl JH, Fauci AS: Transforming growth factor beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986,83:4167-4171.
29. Wiseman DM, Polverini PP, Kanys DW, Lcibovitch JC: Transforming growth factor-p (TGFp) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 1988: 157:793-800.
30. Stoll M, Sleckelings UM, Paul M, Bottari SP, Metzger R, Unger T: The angiotensin AT2-rcceplor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995;95:651-657.
31. 1 receptor: Gain-of-function study using gene transfer. Proc Natl Acad Sci USA 1995;92:10663-10667.
32. Yamada T, Hotiuchi M, Dzau VJ: Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996:93:156-160.
33. Kunert-Radek J, Pawlikowski M: Angiotensin II stimulation of the rat pituitary tumoral cell proliferation in vitro. Biochem Biophys Res Commun 1992;183:27-30.
34. Chen L, Re RN: Angiotensin and the regulation of neuroblastoma cell growth (abstract). Am J Hypertens 1991:4:235.
35. Levy BI, Benessiano J, Henrion D, Caputo L, Heymcs C, Duriez M, Poitevin P, Samuel JL: Chronic blockade of ATi-sublype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996:98:418-425.
36. Scheidegger KJ, Wood JM, van Essen H, Struijker-Boudier HAJ: Effects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats. J Pharmacol Exp Ther 1996;278:1276-1281.
37. Simon G, Altman S: Subpressor angiotensin II is a bifunctional growth factor of vascular muscle in rats. J Hypertens 1992; 10:1165-1171.
38. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF: Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991;17:626-635.
39. Johnson AR, Schulz WW, Noguira LA, Erdös EG: Kinins and angiotensins: Angiotensin 1 converting enzyme (kininase II) in endothelial cells cultured from human pulmonary arteries and veins. Clin Exp Hypertens 1980:2:659-674.
40. Andre P, Schott C, Nehlig H, Stoclet JC: Aortic smooth muscle cells are capable to convert angiotensin I to angiotensin II. Biochem Biophys Res Commun 1990; 173:1137-1141.
41. Rogerson FM, Chai SY, Schlawe I, Murray WK, Marlcy PD, Mendelsohn FAO: Presence of angiotensin converting enzyme in the adventitia of large blood vessels. J Hypertens 1992; 10:615-620.
42. Chatclain RE, Dardik BN: Increased DNA replication in the arterial adventitia after aortic ligation. Hypertension 1988:11:1130-1134.
43. Mecliam RP, Whitchouse LA, Wrenn DS, Parks WC, Griffen GL, Senior RM, Crouch EC, Stenmark KR, Voelkel NF: Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science 1987:237: 423-426.